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Abstract 
 
The self-assembly of amphiphilic peptides is reviewed. The review covers surfactant-
like peptides with amphiphilicity arising from the sequence of natural amino acids, 
and also peptide amphiphiles in which lipid chains are attached to hydrophilic peptide 
sequences containing charged residues. The influence of the secondary structure on 
the self-assembled structure and vice versa is discussed. For surfactant-like peptides 
structures including fibrils, nanotubes, micelles and vesicles have been reported. A 
particularly common motif for PAs is β-sheet based fibrils, although other structures 
have been observed. In these structures, the peptide epitope is presented at the surface 
of the nanostructure, providing remarkable bioactivity. Recent discoveries of potential, 
and actual, applications of these materials in biomedicine and bionanotechnology, are 
discussed.  
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1. Introduction  
 
This Review focuses on recent developments resulting from studies on the self-
assembly of amphiphilic peptides, and applications of these systems which appear 
particularly promising in bionanotechnology and biomedicine. We consider two main 
classes of amphiphilic peptides; these are (i) designed purely peptidic systems with 
amphiphilic properties arising from sequences of hydrophobic and hydrophilic 
(charged) residues, and (ii) peptides modified by attachment of hydrophobic lipid 
chains these are termed peptide amphiphiles (PAs). A distinction is made in this 
review between amphiphilic peptides and PAs, since PAs are a subset of the former 
but not vice versa.  
 
The self-assembly of PAs has recently been reviewed.1 More generally, surfactant-
like peptides and applications have been considered.2 Earlier reviews focussed 
specifically on PAs,3-5 and amphiphilic peptides more broadly.6-8 However, there have 
been numerous developments in the subject even in the last few years since the 
publication of these articles. The purpose of the present Review is to provide a 
focussed tutorial-style update on the topic. The related topic of amphiphilic polymer-
peptide conjugates (eg. attachment of hydrophobic peptides to hydrophilic PEG) is 
dealt with in numerous recent reviews on this topic.9-14 
 
For convenience, in the following the lipid chain length in PAs is denoted Cn where n 
denotes the number of carbon atoms in the chain. The peptide is denoted with single 
letter abbreviation for the amino acids, with end group notation as given in the cited 
literature, i.e. where the end group is specified it is reported here, otherwise not (in 
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most cases this would imply uncapped end groups). Table 1 summarizes the structure 
of the PAs and the nature of the studies discussed in this Review. 
 
 
2. Self-Assembly: Amphiphilic Peptides 
 
Zhang’s groups pioneered studies on the self-assembly of model surfactant-like 
peptides (SLPs). These contain hydrophobic tails having four or more consecutive 
hydrophobic residues attached to a headgroup with two or more charged amino acids.7 
Nanotube, or at least fibril (tube formation is not clear in all cases), formation was 
observed for A6D, V6D, V6D2 and L6D215 and similar peptides containing G instead of 
A as hydrophobic residue.16 In certain cases (eg. G6D2), vesicular structures were also 
reported.16 Fig.1 illustrates a proposed mechanism of nanotube formation by V6D in 
which the nanotube comprises a peptide bilayer.15 The formation of branch points 
such as the three-way junction illustrated was also observed in TEM images. The 
adsorption of V6K2, V6K and V3K at the solid/liquid interface has been studied – 
increased hydrophobicity led to a reduced critical aggregation concentration (cac) and 
an increase in adsorbed amount.17 Defective membrane structures were imaged for 
V6K by AFM. The thickness was consistent with a peptide bilayer, and this could be 
used to immobilize DNA (via electrostatic interaction). SLPs containing basic amino 
acids were also studied and below the pI where the K or H is charged, self-assembled 
structures including nanotubes and vesicles were observed by TEM.18  
 
The self-assembly of Ac-A6K-COOH and Ac-A6D-COOH has been studied in 
particular detail – the cac has been determined (by dynamic light scattering) and 
nanostructures imaged by AFM.19 It was proposed that these were nanotubes, often 
exhibiting periodic bulging (these structures actually resemble twisted fibrils or tapes). 
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Mixing of SLPs such as Ac-A6K-NH2 and Ac-A6D-OH has been investigated, in 
terms of the effect of mixture composition on the cac.20 A substantial decrease in cac 
was observed upon increasing Ac-A6K-NH2 content in the mixture, and this was 
ascribed to a synergistic effect due to balancing of electrostatic interactions. The 
formation of self-assembled twisted fibril structures was observed for Ac-A6D-OH 
alone under appropriate conditions and for certain mixtures of the peptides, above the 
cac.20 Zhang’s group have also developed the well known self-assembling peptide 
RADA-16I [Ac-(RADA)4-CONH2] which forms a fibrillar hydrogel that has great 
utility in stimulating cell growth and for tissue scaffolding.7, 21, 22 It has been 
commercialised as PuraMatrix, however as this is not a surfactant-like peptide further 
details are not provided here. The heptapeptide SLP Ac-GAVILRR-NH2 has been 
shown to form donut-like ring structures in aqueous solution, and this was rationalised 
based on the cone-like structure of the amphiphilic peptide with two bulky charged 
arginine residues forming the headgroup.23  
 
A comparative study of I6K2, L6K2 and V6K2 indicates that I6K2 forms flat ribbon-like 
structures in aqueous salt solution (as imaged by electron microscopy and atomic 
force microscopy), correlated to the formation of β-sheets (probed by CD).24 In 
contrast, L6K2 and V6K2 self-assemble into rod-like fibrils, with CD suggesting 
random coil structures.24 These findings are unusual, in that even short fibrils are 
usually associated with ordered secondary structure (usually β-sheet).  It has recently 
been pointed out that batch-to-batch variation (with concomitant purity variation) can 
affect the observed self-assembled morphology of this type of peptide, in particular 
V6D2, V5DVD and V4D2V2.25 Fibres, tapes and twisted ribbons were observed but not 
the nanotubes and vesicles reported previously by Zhang’s group. Circular dichroism 
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(CD) and HPLC revealed β-sheet features for V6D2 and Ac-V6D2.  HPLC revealed the 
presence of significant fractions of impurities associated with the coupling reaction of 
hydrophobic residues in the peptide.25 
 
The self-assembly properties as a function of hydrophobic tail chain length were 
investigated for A3K, A6K and A9K.26 The cac was determined from conductivity 
measurements and surface tensiometry. Atomic force microscopy (AFM) was used to 
probe the presence, and morphology of aggregated structures. It was reported that 
A3K, which has no apparent detectable cac, forms stacked bilayers, A6K forms 
nanofibres (actually, this system forms nanotubes, vide infra) and A9K forms 
nanorods. Nanorods are distinguished from nanofibres by being short, and lacking 
flexibility. The cac was found to be lower for A9K than A6K, as expected.26 The 
amphiphilic peptides A6K and A9K show antibacterial properties against Gram-
negative E. coli and Gram-positive S. aureus strains, while peptide A3K showed 
almost no activity.27 The extent of antibacterial activity was correlated to the size of 
the hydrophobic unit, which influences the self-assembly of the peptides – only A6K 
and A9K formed well-defined superstructures, these being long fibril-like structures 
and short nanorods respectively. The mode of antimicrobial action was proposed to be 
membrane permeation.27 It has recently been shown that NH2-A6K-COOH self-
assembles into nanotubes (Fig.2),28 with a low dispersity in tube wall thickness (<1 
nm) which might correspond to single wall peptide nanotubes.28, 29 A structural model 
for the peptide packing motif, based on results from X-ray diffraction experiments 
was also proposed (Fig.2).29 
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By mixing these SLPs with lipids, it is possible to control the curvature of the lipid 
membrane and hence the stability of structures such as bicontinuous cubic phases. 
This was specifically investigated in terms of the stability of the Pn3m phase formed 
by monoolein in water.30  
 
Deming and coworkers have developed amphiphilic copolypeptides such as KmLn or 
KmVn where m and n are in the range of tens and hundreds, depending on the 
copolymer.31, 32 They studied their self-assembly properties such as hydrogelation32, 33, 
vesicle formation34-36 or their use in templating structures in silica using CmLn 
copolypeptides.37, 38 Although these systems may be considered “giant amphiphiles”, 
as this work concerns block copolymeric peptides, a detailed discussion is outside the 
scope of this review. Many other reviews on this subject are available.11, 12, 39 
 
Two amphiphilic peptides produced by recombinant DNA techniques, Ac-
A2V2L3WG2-COOH and Ac-A2V2L3WG7-COOH were shown to self-assemble into 
vesicles with relatively low polydispersity in aqueous solution, above a measured 
critical aggregation concentration.40 The formation of vesicles was rationalised based 
on the tapered shape of the molecules, with increasingly bulky amino acid side groups 
towards the hydrophilic domain. The encapsulation of the model water-soluble 
fluorescent molecule calcein was demonstrated. 
 
The aggregation of the naturally occurring surface-active lipopeptide surfactin at air-
water and hydrophobic solid-water interfaces has been studied by neutron 
reflectivity.41 It was found to form a ball-like structure similar to a hydrophobic 
nanoparticle solubilised by charge at the air-water interface. This is an interesting 
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distinct class of PA comprising a cylic heptapeptide headgroup attached to a 
C10(CH3)2 lipid. There are few other reports, to our knowledge, on biomimetic or de 
novo designed PAs based on cyclic peptides. 
 
Amphiphilic peptides can be used to produce peptide particles based on the salt-
induced aggregation of peptides forming micelles with a hydrophobic core and 
cationic corona.42 The peptides comprise hydrophilic lysines and hydrophobicWDL 
repeats (inspired by a sequence from Gramicidin A). The size of the peptide particles 
depended on the position of the counterions in the Hofmeister series. By neutralizing 
the lysines by acetylation, it was possible to drive self-assembly into peptide beads 
which were produced via solvent exchange process. The acetylated peptides are too 
hydrophobic to dissolve in water and so ethanol-water solvent exchange was used.42 
 
 
 
 
3. Self-Assembly: β-sheet forming PA systems 
 
 
In a pioneering series of papers, Stupp’s group has elucidated the principles of self-
assembly of PAs into β-sheet containing nanofibrils. Diverse applications of these 
systems in bionanotechnology are discussed further in section 5 of this review. Figure 
3 shows a representative PA highlighting the structuring motifs incorporated, along 
with a representation of the nanofibril and SEM and TEM image of nanofibrils.5 
Hydrogelation of PA fibril networks can be induced in several ways, such as control 
of pH43 or addition of divalent salts.43, 44 The rheological properties of PA hydrogels 
based on fibrillar networks have been probed in the presence of CaCl2 or HCl.44 The 
gels in CaCl2 have stronger intra- and inter-fibrillar crosslinks due to calcium ion-
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mediated ion bridge formation. To investgiate the role of different components of the 
peptide sequence, and lipid chain length, in a series of homologous PAs on the self-
assembled structure, a series of PAs with varying sequence and total net charge were 
studied.43 Self-assembly into fibrils could be reversibly induced by control of pH 
(Fig.4). In addition, reversible covalent capture of nanofibrils by oxidative cross-
linking of cysteine residues contained in many of the PAs studied was also 
demonstrated (Fig.4). In more recent work on a series of PAs containing VmAmE3 
repeats,45 the influence of hydrogen bond alignment on fibrillar gel stiffness was 
probed by shear rheometry. The extent of hydrogen bond alignment was deduced by 
comparing transmission FTIR with polarization-modulation infrared absorption 
spectroscopy (grazing mode on the sample surface). The fibrils were imaged by cryo-
TEM, and CD was used to measure the level of twisting and disorder of the β-sheets. 
Increasing the number or fraction of valine residues was found to increase the 
stiffness of fibrils, whereas alanines tended to reduce it. This was related to the extent 
of hydrogen bond alignment, and the positioning of β-sheet forming residues near the 
hydrophobic core of the nanofibrils.45 Pyrene and tryptophan fluorescence 
experiments have been used to probe the aqueous environment within PA self-
assembled structures.46 These studies indicate a high degree of solvation in the 
interior. Stern-Volmer quenching constants and the fractional accessibility (of 
covalently bound pyrene) were found to increase as the choromophore is placed closer 
to the aggregate interior. Uptake of chromophore from solution was evidenced by 
solubilisation of free pyrene, and this points to the use of PAs to sequester 
hydrophobic organic molecules congruent with the presentation of bioactive motifs on 
the fibril surface.46 
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Coassembly of PAs with opposite charge within the peptide sequence has been 
investigated.47 Mixed self-assembly occurred due to electrostatic interaction since 
bundles of fibrils of oppositely charged PAs were not observed. Similarly, 
coassembly of PAs with opposite charge on the termini leads to structures with 
enhanced stability compared to those comprising one type of PA molecule only.48 
Reverse PAs containing free N termini were prepared via use of an unnatural amino 
acid modified with a fatty acid chain and these were mixed with conventional PAs 
containing free C termini. Stupp’s group also described the synthesis and aqueous 
self-assembly (info fibrils) of “bola-amphiphiles” (molecule containing two 
hydrophilic headgroups linked by a hydrophobic spacer).49 The formation of 
macroscopic membranes at the interface between two liquids containing aqueous 
solutions of PA and hyaluronic acid (HA) respectively, has recently been described.50 
In a remarkable discovery, it was found that macroscopic sacs or membanes can be 
produced – the membranes can be shaped in moulds, or drawn into strings. The 
membranes are proposed to comprise fibrils of the positively charged PAs, around 
which negatively charged HA polymer chains are decorated. Possible applications of 
the sacs/membranes in biotechnology such as cell encapsulation or barrier materials 
were proposed. 
 
Molecular dynamics computer simulations have shed light on the self-assembly 
process of PAs, leading to a “phase diagram” parameterized in terms of the hydrogen 
bonding strength versus hydrophobic attraction strength.51 The phase diagram 
contains regions corresponding to long cylindrical fibrils, micelles, single β-sheets, 
stacks of β-sheets and amorphous aggregates. 
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The formation of tape-like structures termed “nanobelts” (Fig.5a-c) has recently been 
described.52 The de novo designed PAs such as C16O-VEVE form strands containing 
charged and hydrophobic faces. This leads to the formation of tapes containing PA 
bilayers parallel to the flat surface of the tapes. The tapes present peptide epitopes 
(within β-sheets) at the surfaces (Fig.5d). The important role of electrostatic 
interactions is highlighted by the ability to reversibly break tapes into grooved tapes 
(Fig.5d). The unravelling of the tapes into twisted fibrils can be observed in dilute 
solution (Fig.5e,f). Twisted nanoribbons were also observed for the PA C16O-
VEVEGRGD containing the RGD cell adhesion motif.52 The mechanism of the 
transformation from twisted ribbons into helical ribbons for a PA containing 
phenylalanine repeats has been elucidated by state-of-the-art cryo-TEM 
experiments.53 A sample in which the F3 repeat was replaced with A3 formed 
cylindrical fibrils, pointing to the importance of the F residues which undergo π-π 
stacking interactions in driving the self-assembly into ribbons.  The transition in the 
arrangement of the β-strands within the aggregates is related to the most stable 
packing motif of the PAs.45  
 
The self-assembly of branched PAs and their use to present the RGDS cell adhesion 
motif has been described.54 Self-suporting fibrillar hydrogels were observed in the 
presence of physiological fluids such as synovial fluid and DNA. Tryptophan 
fluorescence experiments indicated that there is greater mobility in the aggregates of 
branched PAs than linear analogues. More information on the use of RGD(S) 
functionalized PAs in stimulating cell growth or adhesion, relevant for example to 
tissue engineering, is discussed in Section 5.1.  
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In another proof-of-concept demonstration, Stupp’s group showed that PA nanofibrils 
can be decorated with receptors to template the deposition of target lipophilic gold 
nanoparticles.55 The PA fibrils were prepared by co-assembly with PAs containing 
thymine moiety. Lipophilic gold nanoparticles were functionalized with the 
complementary DAP (diaminopyridine) moiety, which drives binding with the 
nanofibrils when the nanoparticles are mixed in solution. Further details on the use of 
PAs in biomineralization are provided in section 5.3.55 
 
An X-ray radiation- induced disorder-order transition was observed for PA C16-A6E3 
(and related PAs).56 In dilute solution, this system underwent a transition from an 
isotropic phase to a hexagonal phase upon exposure to synchrotron X-rays, i.e. two-
dimensional liquid crystal ordering of the fibrils was induced (Fig.6a). The transition 
was found to be reversible, and was ascribed to X-ray induced charging of the fibrils 
due to reversible ionization of the COOH groups. The role of electrostatic interactions 
was confirmed by salt screening experiments. A mechanism for templated growth of 
filament bundles was proposed (Fig.6b). 
 
It has recently been discovered that aligned threads of PAs can be created by injecting 
noodle-like strings of PA solution (after heat treatment) from a pipette into a saline 
solution or dragging a thread of PA solution across a film of CaCl2 (Fig.7a-c).57 The 
strings contain bundles of highly aligned fibrils. The heat treatment comprises heating 
PAs to above the lipid chain melting temperature (to 80 oC), cooling back to 25 oC 
and addition of CaCl2 and this leads to the formation of birefringent gels (Fig.7d). 
This thermal pathway leads to a lamellar plaque structure, which ruptures into bundles 
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of nanofibres on cooling (Fig.7e,f). An analytical model for this was presented. The 
extruded PA strings could be used to preferentially align encapsulated cells.57 
 
The influence of alkyl chain length on the self-assembly in aqueous solution of a 
designed amyloid forming peptide Ac-KTVIIE-NH258 was investigated, with a 
specific focus on thermal stability as probed by CD and TEM.59 The stability of β-
sheet self-assemblies against dilution and temperature was enhanced for C12, C14 and 
C16 chains, in contrast to PAs with shorter alkyl chain lengths (C6 and C8). In a 
development of this work, the influence of C-terminally attached hydrophilic PEG on 
the self-assembly was examined.60 A PEG-peptide was shown not to self-assemble, as 
expected due to the high hydrophilicity. However, to study the balance between 
hydrophilic destabilization and hydrophobic stabilization, PEG was also C-terminally 
attached in a PA (containing the same KTVIIE peptide sequence). By linking the C18 
alkyl chain via a nitrobenzyl group it was possible to cleave the hydrophobic tail 
using UV radiation leading to disruption of β-sheet structure and hence destruction of 
fibrillar structures.60  In a previous study by this group of PAs containing the 
nonapeptide GANPNAAG based on a protein from a malaria parasite protein, distinct 
self-assembled motifs were identified depending on alkyl chain length.61 CD revealed 
that C6, C10 and C12 derivatives adopted random coil conformations, independent of 
temperature whereas C14 and C16 derivatives underwent a transition from β-sheet at 
room temperature to random coil at high temperature. The transition temperature 
increased from C14 to C16 (but not for C18).61 These results point to the delicate 
balance between hydrophobicity and electrostatic interactions in thermally stabilizing 
self-assembled PA structures in aqueous solution. 
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The van Hest group has investigated the polymerization of PAs containing 
diacetylene units.62 The influence of the placement of the diacetylene moiety (Fig.8a) 
on the chromatic properties (UV/vis absorption spectrum) was examined, this being 
influenced by conjugation length of the polydiacetylenes and the packing of groups 
either side of the diacetylene units.62 One of these PAs has been used to demonstrate 
spatially selective polymerization (mechanism shown in Fig.8b) using polarization 
holography on films in which fibrils were aligned in the presence of a strong magnetic 
field.63 The magnetic alignment of this system was studied in prior work, in which 
conditions to achieve alignment were examined in more detail.64 
 
The influence of amino acid sequence on the self-assembly of designed PAs 
containing C16 chains and dodecapeptides with variable position of A residue within a 
hydrophobic sequence of N-terminal G residues and a C terminal charged ERGDS 
sequence has been examined.65 Shifts in the position of the alanine residue affect the 
hydrogen-bonding pattern and packing of the peptides leading to differences in 
secondary structure. The presence of the chiral alanine residue simplifies 
interpretation of the CD spectra. It was found that four core hydrogen bonds are 
required to form β-sheet structures, whereas if the A residue is located in the core 
region, this is disrupted and a polyproline II –type secondary structure is adopted 
instead. This paper also describes the use of FTIR to deduce information on the 
orientation of the β-sheet forming PAs with respect to the fibril axis, through 
comparison of transmission FTIR on a bulk sample and ATR-FTIR on a film. This led 
to the conclusion that the PA molecules are arranged radially, perpendicular to the 
fibril axis (Fig.9).65 Hartgerink’s group has also developed PAs to form nanofibers to 
catalyse the formation of silica nanotubes.66 The PAs comprise C16O chains attached 
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to AmX4 peptides where X is K, H or E and these were used to template the 
polymerization of tetraethoxysilane (TEOS). 
 
Lipidation to produce PAs can change the arrangement of secondary structure 
elements (in addition to influencing the secondary structure itself). For example, it has 
been demonstrated using solid state NMR techniques that attachment of an octanoyl 
chain drives the formation of parallel β-sheets in a PA containing Aβ(16-22) [Aβ 
denotes the amyloid β peptide] whereas the native heptapeptide forms antiparallel β-
sheets.67 The amphiphilicity dominates the self-assembly process as the hydrophobic 
residues are shielded from the aqueous environment, in contrast to the preponderant 
intermolecular hydrogen bonding and electrostatic interactions for the native peptide.  
 
It is possible to prepare monolayers, and measure the surface-pressure area isotherms 
of PAs at the air/water interface by Langmuir-Blodgett film techniques.68 This was 
investigated in detail for a series of dipalmitoyl PAs. At high surface pressure, it is 
possible to compress the PAs such that the chains become fully extended. The surface 
pressure –area characteristics are determined by the peptide head group length and its 
sequence.68 The formation of ordered monolayers comprising β-sheet lipopeptides at 
the air/water interface has been reported.69 The structural model was largely based on 
grazing-incidence X-ray diffraction complemented by Brewster angle microscopy and 
surface pressure/area isotherm measurements, while secondary structure was probed 
by CD and FTIR. 
 
A sequence from the amyloid β (Aβ) peptide that favours α-helical secondary 
structure was incorporated into a PA with a C12 chain.70 The critical micelle 
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concentration (cmc) was determined at two pH values. At pH 10, β-sheet features 
were observed by CD showing that conjugation of the peptide to a lipid chain favours 
β-sheet formation under conditions where the charge on the peptide is reduced 
(compared to pH 3), enabling hydrogen bonding to occur. Fibrillisation was observed 
by AFM including the formation of tape-like fibrils at sufficiently high concentration. 
The formation of twisted nanoribbons was related to the formation of β-sheets at pH 
10.70 In related work, the self-assembly of PAs containing the amyloidogenic 
amylin(20-29) sequence was investigated.71 Addition of a single β-aminoethane 
sulfonamide moiety was found to distupr amyloid fibril formation. Alkylation of the 
sulphonamide restored fibrillisation and led to hydrogelation. Variation of alkyl chain 
length influenced the self-assembled structure which varied from helical and twisted 
ribbons through to entangled fibres. CD did not provide clear information on 
secondary structure for all of the PAs.71 
 
4. Self-Assembly: α-helical PA systems 
 
 
As discussed in the preceding section, attachment of alkyl chains can stabilize 
secondary structure in PAs. This has also been demonstrated for α-helical peptides. In 
a series of papers, Fields and coworkers have investigated the lipid-induced 
stabilization of collagen-based peptides forming helical secondary structure.72-74 
Initial work established that a series of dialkyl chain collagen-based PAs formed 
polypro II triple helical structures, and that lipidation enhanced the thermal stability of 
the helical conformation, compared to the peptides alone.72 For a series of PAs with 
varying alkyl chain length (from C6 to C16 monoalkyl, even chain length and (C12)2 
dialkyl), the helix-coil “melting temperature” was located by CD. It was found to 
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increase with alkyl chain length, pointing the stabilization of the collagen-like triple 
helical conformation. This was also monitored by 1H NMR spectroscopy (specifically 
probing the environment of the W residue).73 Forns et al. studied PAs containing a 16-
residue peptide containing a heptad repeat designed to form coiled coil structures and 
also a 39 residue peptide containing a collagen-based sequence forming a triple 
helical structure.74 Addition of C6 or C16 chains to the 16 residue peptide induced α-
helix formation, absent for the peptide on its own. The thermal stability of the α-helix 
was greater for the C16 PA. Similar findings in terms of enhanced thermal stability 
were reported for the 39 residue peptide (which however does form helical structure 
without the attached lipid chain).  
 
Wormlike micelle formation has been noted for a C16 PA containing a designed 
peptide WA4KA4KA4KA with a propensity to form α-helices.75 The initially formed 
morphology was spherical micelles and the secondary structure comprised a mixture 
of α-helical and random coil structures. The structure transformed into wormlike 
micelles over a time period ~ days, accompanied by a transition to a β-sheet 
secondary structure. 
 
The self-assembly of PAs comprising pentapeptides containing the RGD cell adhesion 
motif attached to C11 or C12 alkyl chains, or an Fmoc moiety, has been examined. 
TEM suggested a variety of structures (micelles, vesicles or pH) depending on the 
peptide sequence and pH.76 CD suggested contribution from α-helical structure, 
especially at higher pH. 
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A PA containing a DNA-binding motif along with a coiled-coil inducing heptapeptide 
sequence has been shown to self-assemble into helical ribbons and tubules.77 CD 
indicated an α-helical conformation for the peptide. Addition of co-surfactant (SDS) 
led to the formation of spherical micelles. The subject of gene delivery by DNA 
condensation is discussed further in section 5.2. 
 
5. Applications 
 
 
5.1 Tissue Scaffolds 
 
One of the most common motifs for cell adhesion studies within the field of PAs, and 
more broadly is the integrin recognition motif RGD(S) from fibronectin. In pioneering 
work, Tirrell’s group attached linear RGD (via amino or carboxyl units) to dialkyl 
lipid chains, and also prepared a conjugate containing looped RGDS (connected via 
linkers to dialkyl chains on each side).78 Concentration-dependent spreading of 
melanoma and endothelial cells was observed on Langmuir-Blodgett films of the 
looped PA, whereas indiscriminate spreading was observed for the carboxyl-coupled 
PA, and no spreading was found for the amino-attached PA. Adhesion was not 
observed using control PAs containing looped RGE, and it was also blocked for the 
looped RGD PA by antibody inhibition of integrin receptors.78 Prior to this, Oku et al. 
had investigated RGD-based PAs in a study on liposomes for cancer metathesis.79 The 
PAs were found to inhibit spontaneous metastasization. 
 
The incorporation of the RGD adhesion motif in PAs was also discussed by Marchi-
Artzner et al.80 They synthesized several di-alkyl lipid chain PAs containing the 
cyclic[RGDF(K)] [(K) denotes attachment of the cyclic peptide through the lysine ε-
amino group]  peptide and studied adhesion to integrins (αIIbβ3 from human blood 
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platelets) tethered to glass substrates. Fluorescently labelled PAs were incorporated 
into vesicles and the adhesion of the vesicles was investigated by interference 
microscopy and fluorescence microcopy. These results shed light on the selective 
interaction of RGD-functionalized giant vesicles with endothelial cells. The adhesion 
and spreading of these cells, and also of human umbilical cord on solids 
functionalized with the RGD PAs was demonstrated.81 The spreading and adhesion of 
endothelial cells in multiwall plates coated with a PA has been investigated.82 The PA 
incorporated a 16-residue α-helical promoting domain and a sequence from the 
SPARC cellular matrix protein associated with collagen. The 119-122 sequence from 
SPARC is known to stimulate endothelial cell proliferation and angiogenesis. The 
self-assembly of the PAs was also investigated – CD revealed a predominantly α-
helical structure, and an increase in thermal stability with increasing alkyl chain 
length. The best cell adhesion properties were obtained by mixing the SPARC-based 
PAs with a PA incorporating the α2β1 integrin binding site from type I collagen and a 
pseudolipid.82  
 
Hartgerink’s group have investigated the viscoelastic properties of PA fibrillar 
hydrogels, induced in the presence of divalent (calcium) ions.83 The PAs contained 
the RGDS cell adhesion motif, as well as a proteolytically degradable sequence 
specific for MMP2, GTAGLIGQ. They also demonstrated the encapsulation of neural 
cells within the hydrogels, and the degradation of the networks using collagenase.  
 
Stupp’s group have made important breakthroughs in demonstrating potential 
applications of PAs in regenerative medicine. For example, the selective 
differentiation of neural progenitor cells using PA nanofibrils containing peptides 
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incorporating the IKVAV cell adhesion motif from laminin has been established.84 
The cells were encapsulated within a three-dimensional fibrillar gel and rapidly 
differentiated into neurons, in contrast to control peptides, for example non-lipidated 
laminin or poly(D-lysine). The same PA was shown to be effective in treating spinal 
cord injury using a mouse model.85 The self-assembling nanofibers inhibited glial scar 
formation and to promote axon elongation. 
 
Stupp and coworkers have shown that PAs presenting the RGDS cell adhesion motif 
can be used as scaffolds for therapeutic delivery of bone marrow derived stem and 
progenitor cells.86 Optimal cell adhesion was found for a binary PA system 
comprising 10 wt% RGDS-based PAs and 90 wt% C16-V3A3E3 charged diluent 
(“filler”) PA molecules. A bioactive peptide mixed with a filler peptide has also been 
applied to cartilage regeneration.87 The bioactive peptide incorporates a transforming 
growth factor β1 (TGF-β1) binding domain. The fibrillar gel incorporating the TGF-
β1 binding domain released TGF-β1 more slowly than a gel prepared from the non-
bioactive PA alone. The chondrogenic differentiation of human mesenchymal stem 
cells was shown, as was the regeneration of articular cartilage in a rabbit model.87 In a 
further development relevant to future tissue bioengineering, Stupp’s group have 
shown that angiogenesis, i.e. the production of new blood vessels, can be stimulated 
using PAs contain a heparin-binding sequence that self-assemble into nanofibrils that 
present the bioactive motif at their surface.88 
 
A hierarchical method to align human mesenchymal stem cells based on a 
polymerizable PA system has been reported.89 The PAs contain diacetylene units in 
the lipid tails which undergo UV-induced polymerization (cf. Fig.8). The functional 
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peptide contains the RGDS cell adhesion motif. Alignment was induced by soft 
lithography techniques, i.e. compression of the PA solution in channels using PDMS 
moulds in the presence of base which neutralizes charge and causes self-assembly of 
the PAs which, aligned by flow fields on compression, were then polymerized by 
exposure to UV irradiation. The use of soft lithography without cross-linking of PAs 
as an alignment tool had been demonstrated earlier by the Stupp group.90 Solvent 
evaporation within the elastomeric stamp lead to orientation of nanofibers parallel to 
the channels, and it was suggested that this might occur via a lyotropic liquid 
crystalline phase. 
 
 
Matrixyl is the tradename for the commercial PA, C16-KTTKS which was patented by 
Sederma S.A. (France) for use in personal care and cosmetic applications in particular 
for treatment of visible signs of aging such as wrinkles.91 This is actually the only PA 
in use in the market at present, to our knowledge. A number of reports on its 
application in cosmetics in anti-wrinkle treatments are available in the open 
literature.92-95 PAs C16-GHK and C16-GQPR are of interest for similar applications, 
and a method to assay PA content in anti-wrinkle creams based on LC/MS has been 
reported.93 Our group has recently investigated the self-assembly of this system in 
detail and we have shown that C16-KTTKS forms large fibrillar superstructures, with 
lengths extending to at least 10-100 mm (Fig.10a,b).96 These fibrils are based on 
nanotapes (with nanoscale width and thickness), the structure of which was elucidated 
by SAXS and shown to comprise PA bilayers parallel to the tape surface (Fig.10c). 
Understanding the self-assembled motif is expected to be important in controlling the 
formulation and hence collagen-stimulating activities (this is currently under 
investigation by our group). 
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Kokkoli and coworkers have been exploring the use of PAs containing the GRGDSP 
cell adhesion motif and the PHSRN synergy motif in the development of hydrogels 
for tissue scaffolding.97-101 They investigated the binding of PAs containing one or 
both of these motifs to α5β1 integrins by AFM.97, 98 The PAs formed Langmuir-
Blodgett monolayers (the surface pressure/area characteristics of which could also be 
controlled) deposited onto mica and the integrins were attached to AFM tips by 
immobilization using antibodies. The recognition of the immobilized receptor was 
significantly enhanced for the PAs presenting both GRDSP and PHSRP sites.97 
Mixing a PEG lipid (DSPE-PEG) with PAs containing both motifs was found to 
facilitate adhesion, an observation ascribed to enhanced presentation of PHSRN due 
to enhanced packing of the peptide headgroups.98  The influence of linker groups 
(before the PHSRN group and between this and the RGDSP domain) has been 
examined in a similar manner – leading to the conclusion that a short spacer is 
optimal.100 This group have recently optimised the design of the PA [C16-
G3S2PHSRN(SG)5RGDSP] to incorporate a linker that favours β-sheet formation as 
well as a single alkyl chain.101 These features are shown to enable self-assembly into 
nanofibrils, and hydrogelation occurs for sufficiently concentrated samples. The 
adhesion and proliferation of HUVEC cells were studied, as well as fibronectin 
production (fibronectin being an important part of the ECM). This peptide was 
superior to peptides studied earlier by this group such as the closely related peptide 
C16-KSSPHSRN(SG)5RGDSP99 due to the inclusion of the G3S2 linker unit. The 
performance of these materials was good in comparison to other hydrogels, including 
those containing PEG and commercially available systems such as PuraMatrix based 
on Ac-(RADA)4-CONH2 discussed in section 2 above.101 
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5.2 Delivery and Cell Internalization 
 
Transport of hydrophobic drugs or other actives into cells remains an important 
challenge in biomedicine. A PA-based nanocarrier system with the potential to 
become internalized wihin the cell has been researched.102 The PA comprises the 
tandem dimer (LRKLRKRLLR)2 that contains binding sites for the low-density 
lipoprotein receptor and for cell-surface heparin sulphate proteglycans. The peptide 
was conjugated to a dipalmitoyl lipid tail. The cmc was found to be extremely low 
and vesicles were prepared by mixing with a conventional lipid. Internalization of 
fluorescently labelled PA within endothelial cells was imaged.102 
 
The mechanism of internalization of a PA comprising a pro-apoptotic peptide derived 
from the p53 tumor suppressor protein attached to a C16 lipid chain has been 
investigated via fluorescence mechanisms using mixtures of unlabelled and 
rhodamine-labelled PAs.103 Self-assembly into rod-shaped micelles was reported. 
Based on analysis of self-quenching of tryptophan-dansyl fluorescence (FRET), 
internalization into model liposomes was found to occur in the form of monomers 
rather than micelles. It was also concluded that attachment of the C16 chain led to 
enhanced uptake into cells (using an osteosarcoma cell line) compared to the 
unmodified peptide (Fig.11).103 
 
Yang’s group has investigated the use of amphiphilic peptides containing cationic 
peptide sequences for applications in gene delivery.104-106 Cholesterol-conjugated 
H5R10 and H10R10 were shown to self-assemble into cationic micelles, leading to an 
increase in localized charge (compared to the molecules without attached cholesterol) 
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and an increase in DNA binding.106 Gene expression, probed using a luciferase 
reporter model, into Hep62 and HEK293 cells was demonstrated, with an 
enhancement in efficiency for the peptide containing ten histidine residues. The 
luciferase expression was assayed as a function of N/P [nitrogen/phosphate] ratio 
(which influences micelle size and zeta potential).104 In a parallel study, A12H5K10 and 
A12H5K15 were investigated.105 The cytotoxicity profile (using HEK293, HepG2 and 
4T1 cell lines) was favorable compared to polyethyleneimine (PEI), widely used as a 
synthetic DNA-condensing polymer in gene delivery studies. Luciferase expression 
was significantly improved compared to the control H5K10 non-amphiphilic peptide. 
Interestingly, TEM revealed that micelles of the two amphiphilic peptides studied had 
a cubic morphology, as did the complexes with DNA.105 Simultaneous delivery of a 
drug and gene was investigated using Ac-(AF)6H5K15-NH2.106 The model drug 
employed was doxorubicin and the model genes were luciferase reporter gene or p53. 
The amphiphilic peptide was found to self-assemble into micelles, above a cmc. These 
micelles were able to encapsulate doxorubicin and condense DNA. Co-delivery and in 
vitro expression were demonstrated using HepG2 cells. Amphiphilic peptides 
containing oligo-arginine repeats have also been shown to be efficient in gene 
delivery.107 Octa-arginine repeats were found to be optimal, and incorporation of 
histidine groups aids endosomal escape since the imidazole sidegroup is able to 
scavenge protons upon internalization in acid intra-cellular compartments. 
 
The bioresponsive delivery of the anticancer agent cisplatin using a PA has been 
examined.108 The PA contained a cell-adhesive MMP-2 sensitive peptide domain and 
it was shown to self-assembled into fibrils. Hydrogelation was induced by 
complexation of the D residues or carboxyl termini in the peptide with cisplatin (Fig. 
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12). Release of cisplatin by enzymatic degradation of the MMP-2 sensitive sequence 
was demonstrated. 
 
Kros and coworkers have developed a simple PA-based model for membrane fusion, 
based on models for SNARE [soluble NSF attachment protein receptor, NSF = n-
ethylmaleimide-sensitive factor] proteins.109 The PAs comprise DOPE lipid chains 
linked via PEG12 spacers to coil peptides containing heptad repeats which contain 
complementary E and K residues (Table 1). By creating populations of liposomes 
with either of the two PAs incorporated in the lipid membrane, membrane fusion 
could be induced by mixing the liposomes which causes coiled coil formation due to 
salt bridging of the complementary residues.  
 
 
5.3 Antimicrobial Properties 
 
Lipidation of cationic peptides can improve their antimicrobial properties, as 
highlighted by Tirrell and coworkers.110 They showed enhanced antibacterial activity 
for two of the three PAs studied, but not the third which differed in sequence and had 
a lower increase in α-helical content upon conjugation of the lipid chain than the 
other two. Changes in secondary structure in the presence of liposomes were probed 
by CD. This led to the overall conclusion that increases in haemolytic activity and 
antimicrobial activity are correlated to changes in a-helical structure as the peptides 
interact with lipid membranes and that PAs can promote this, by enhancing the ability 
to form secondary structures. Shai and coworkers investigated the influence of PAs 
containing cationic K-based di- and tri-peptides on antimicrobial and antifungal 
activity using a range of Gram-negative and Gram-positive bacteria, and two fungal 
strains.111 The mode of action was identified as bacterial leakage caused by 
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permeation and disruption of cell membranes, in common with many other 
antimicrobial peptides and polymers. Potent in vivo activity against C. albicans was 
shown, using a mouse model. PAs C16-KKK and C16-KGK were most active. The 
substitution of selected LK residues with DK was found not to affect the activity of the 
lipopeptides. These authors also mentioned that antimicrobial lipopeptides are 
produced nonribosomally in bacteria and fungi during cultivation.111 
 
A cholesterol-based amphiphilic peptide containing a TAT sequence has been shown 
to be an effective antimicrobial agent.112 TAT peptides are widely used to transport 
peptides and proteins across cell membranes,113 and a short TAT domain was attached 
to a polyarginine sequence to further improve membrane translocation, and to confer 
antimicrobial properties. The amphiphilic peptides self-assemble into micelles and 
were shown to be effective against S. aureus infection in mice and rabbits. In the 
latter case, transport across the blood-brain barrier and reduction of bacterial growth 
in infected brains was demonstrated.112 
 
PAs with potential application in the treatment of sepsis has been investigated.114 
Sepsis is produced by bacterial endotoxins, lipopolysaccharides (LPS). These are a 
major component of the cell wall of Gram-negative bacteria. The immune system can 
recognise LPS and this was used as basis to design a PA based on an LPS binding 
cyclic 14-residue peptide (LALF). The LPS neutralizing activity was assayed and 
found to increase with alkyl chain length. Cytotoxicity was also examined. The PAs 
were found to self-assemble into micelles. Two other LPS-binding peptide sequences 
termed BPI and SAP were incorporated into C16 PAs – these self-assembled into 
fibrils.114  
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 As described above, the antimicrobial properties of A3K, A6K and A9K have also 
been investigated.27 
 
 
5.4 Biomineralization 
 
The biomineralization of the artificial bone mineral hydroxyapatite can be templated 
using PAs.115, 116 In the first demonstration of this concept, the design of the PA was 
carefully explained. The peptide comprises sequentially a C4 group which can be 
crosslinked to form disulfide links, a flexible G3 spacer, a phosphorylated serine 
residue to interact with calcium ions and a terminal RGD cell adhesion motif (Table 
1). Self-assembly into nanofibrils was reversible by variation of pH and the oxidative 
cross-linking via disulfide bond formation is also reversible upon addition of a 
reducing agent such as DTT.115 A nanofiber gel matrix can be used to template 
hydroxyapatite crystallization via the enzyme alkaline phosphatase in the presence of 
β-glycerolphosphate as a source of organic phosphate. Hydrogelation was induced by 
addition of calcium chloride which screens charge and enables ionic bridging to create 
a network structure in the self-supporting gel. Control experiments using collagen or 
alginate gels showed that mineralization did not occur using these systems as 
matrices.116 
 
A lipopeptide comprising a phospholipid (DOPE, dioleoyl phosphatidyl 
ethanolamine) conjugated to a (LG)4 octapeptide has been used to template the 
biomineralization of Ca2+, generating a distinct crystal habit of calcite.117 The peptide 
sequence is based on a design shown to form β-pleated sheet structures at the 
air/water interface. Attachment of the lipid chain enhanced amphiphilicity, and an 
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ordered antiparallel β-sheet structure was formed that exposed an array of carboxylate 
groups to the aqueous phase, templating the formation of specific crystal orientations 
of CaCO3. 
 
5.5 Miscellaneous Applications 
Several SLPs were shown to be effective in enhancing the stability of membrane 
proteins in solution.118, 119 Peptides A6D and A6K were shown, via rhodopsin UV/vis 
adsorption kinetic measurements, to stabilize G-protein coupled receptor bovine 
rhodopsin against thermal denaturing with or without surfactants (lipids or other 
surfactants).118 Use of SLPs to improve the photochemical activity of the multidomain 
protein complex Photosystem-I (PS-I) was also demonstrated, as has the stabilization 
of PS-I in its functional form in aqueous solution, in terms of kinetic or thermal 
stability.119 The most active compounds were Ac-I6K2-CONH2 and Ac-A6K-CONH2. 
This type of SLP (specifically the latter compound) has also been used to stabilize PS-
I for use in solid-state electronic devices (photodetectors and photovoltaic devices),120 
since it can stabilize the protein on a dry surface for an extended period.121  
 
Synthetic virus-like particles based on PA micelles have been shown to stimulate 
antibody production based on model synthetic antigens.122 The antigens were 
presented on the surface of the self-assembled nanoparticles. The peptide component 
of the PA was a coiled-coil sequence derivd from the heptad repeat region 1 (HR1) 
from the F1 glycoprotein of respiratory syncytial virus. The work has the potential to 
be extended to biologically relevant epitopes such as T-helper cell epitopes. 
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Use of PAs as mild denaturing agents has been described. The lipopeptides form 
cylindrical micelles, presenting α-helical peptide at the periphery.123 The dispersal of 
phospholipid membranes was ascribed to the ability of the alkyl chains in the PA to 
pack in a membrane-like manner.  
 
PAs have been used to create bioactive micelles with applications as potential target-
selective contrast agents for MRI.124 The PAs self-assembled into micelles presenting 
octreotide on the exterior, forming an antiparallel β-sheet structure. Octreotide is a 
cyclic eight residue somatostatin analogue, which could be capable of targeting 
receptors for human tumors. 
 
The encapsulation of carbon nanotubes by PAs has been investigated.125 The branched 
PAs employed (anionic or cationic model systems) act as surfactants, with the 
additional advantage that biofunctionality (demonstrated using the RGD cell adhesion 
motif) can be introduced at the nanotube surface. The presentation of biotin on 
RGDS-containing nanofibers formed by branched PAs has also been examined.126 
 
 
6. Conclusions 
 
 
Amphiphilic peptides are beginning to attract immense interest due to their 
outstanding potential in biomedical and bionanotechnological applications. Their self-
assembly can be controlled in order to present bioactive peptides at the surface of 
fibrils, tubes, vesicles and other self-organized structures. Considering the potential of 
these materials compared to say, lipids or peptides as individual components, the 
literature to date is surprisingly quite limited. Although possibly not complete (we 
 29
apologise to authors of work we have omitted), there appear to only be ~100-200 
papers on this subject to date. We expect an explosion of further research in this area 
as new directions open up. 
 
Undoubtedly, fibrils are the most commonly observed self-assembled structures for 
amphiphilic peptides. Vesicular and tape-like structures have also been observed. It 
would appear that the observation of these morphologies can be rationalised based on 
the geometrical surfactant packing parameter model.127 However, this has not yet 
been quantitatively investigated for amphiphilic peptides. It has been used as a 
general rule to understand the formation of vesicles, cylindrical and spherical micelles 
by amphiphilic block copolymers.128  
 
In this review, details are provided on the self-assembly of amphiphilic peptides of 
which most work has been on model de novo designed surfactant-like peptides such 
as A6K and A6D. Despite this work, basic questions such as the structure of the self-
assembled structures have not until very recently been elucidated in detail and there 
are still outstanding important questions, such as what drives the formation of 
nanotubes and what sets the thickness of the nanotube wall, whether it is a single- or 
multi-wall nanotube. We have seen that these simple peptides may have important 
applications e.g. in antibacterial coatings due to the ability of short cationic sequences 
in amphiphilic peptides to disrupt cell membranes. It will be important to ensure in 
applications that this occurs selectively with bacterial membranes, and not the cell 
membranes of eukaryotes. 
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The field of PAs has recently generated a set of very high profile breakthroughs 
concerning use of these materials in bioengineering, specifically in the development 
of biomaterials for cell growth and controlled differentiation, with applications in 
tissue scaffolding, bone development, collagen production, nerve regeneration etc. 
There are many other outstanding applications in regenerative medicine that rely on 
the ability of PAs to self-assemble into structures with a lipidic core, around which 
peptide epitopes are presented at high density. It is hoped that this review provides a 
snapshot of a very dynamic research environment in this field. 
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Table 1. Amphiphilic peptide systems* 
 
Amphiphilic Peptide Peptide 
Design 
Nature of Study Ref. 
Surfactant-Like Peptides 
A6D, V6D, V6D2, L6D2 de novo 
design 
Nanotube formation 15 
G4D2, G6D2, G8D2, G10D2 de novo 
design 
Nanotube and vesicle 
formation 
16 
V6K, V6K2, V3K de novo 
design 
Adsorption at the 
air/solid interface, 
DNA immobilization 
17 
V6K2, L6K2, A6K, V6H, V6K, H2V6, KV6 de novo 
design 
Nanotube and vesicle 
formation 
18 
Ac-A6D-COOH and Ac-A6K-COOH de novo 
design 
Self-assembly and cac 
determination 
19 
Mixtures of Ac-A6D-OH and Ac-A6K-NH2 de novo 
design 
Synergistic effects on 
cac, and observation of 
twisted fibrils 
20 
Ac-GAVILRR-NH2 de novo 
design 
Formation of 
“nanodonut” structures 
23 
I6K2, L6K2, V6K2 de novo 
design 
Self-assembled 
morphology correlated 
to secondary structure 
24 
V6D2, V5DVD, V4D2V2 de novo 
design 
Influence of sequence 
and purity on self-
assembly 
25 
Determination of cmc, 
self-assembled 
structures 
26 A3K, A6K, A9K 
 
de novo 
design 
 
Antibacterial properties 27 
Nanotube formation 28 A6K de novo 
design Nanotube structure 29 
Ac-A2V2L3WG2-COOH and Ac-A2V2L3WG7-
COOH 
de novo 
design 
Formation of vesicles 40 
chol-H5R10, chol-H10R10 
chol denotes cholesterol 
de novo 
design 
Gene delivery 104 
A12H5K10, A12H5K15 and H5K10 (non-amphiphilic 
control) 
de novo 
design 
Gene delivery 105 
Ac-(AF)6H5K15-NH2 de novo 
design 
Co-delivery of drug and 
DNA (gene delivery) 
106 
NH2-I5H4R8-CONH2, NH2-F5H4R8-CONH2, 
NH2-W5H4R8-CONH2, NH2-H4R8-CONH2, 
de novo 
design 
Gene delivery 107 
chol-G3R6TAT 
TAT = YGRKKRRQRRR 
Contains 
TAT 
sequence 
Antimicrobial properties 112 
A6D and A6K de novo 
design 
Stabilization of  
G-protein coupled 
receptor bovine 
118 
 37
rhodopsin against 
denaturing 
Ac-V6R2-NH2, Ac-V6K2-NH2, Ac-A6K-NH2, Ac-
I6K2-NH2, Ac-A6K-OH, DA6-NH2, Ac-V6D2-NH2, 
Ac-A6D-OH, KA6-NH2 
de novo 
design 
Stabilization of  
Protein complex 
Photosystem-I and 
enhancement of activity 
119-121 
H-K3-[WDL]3-W-NH2, H-CK3-[WDL]3-W-NH2, 
Ac-[K(Ac)]3-W-[WDL]3-W-NH2 , Ac-C[K(Ac)]3-
W-[WDL]3-W-NH2, Ac-C(sl)[K(Ac)]3-W-[WDL]3-
W-NH2  
sl denotes the spin label acetamidoproxyl 
de novo 
design 
Micelle aggregation and 
formation of particles 
and beads 
42 
Lipidated Peptides 
Cn-C4G3S(Phos)RGD n = 6,10,16,22 
Cn-A4G3S(Phos)RGD n = 10,16 
C16-C4G3S(Phos), C16-C4G3S(Phos)KGE  
C16-C4G3S(Phos)RGDS, C16-C4G3SRGD, C16-
C4G3EIKVAV 
 
S(Phos) denotes phosphorylated serine 
de novo 
design 
Influence of PA 
structure on self-
assembly, and covalent 
capture by disulfide 
cross-linking 
43 
C16O-V3A3E3 de novo 
design 
Mechanical properties 
of hydrogels 
44 
C16O-V3A3E3, C16O-V2A2E3, C16O-V4A4E3, C16O-
V2A4E3, C16O-V4A2E3, C16O-A3V3E3 
de novo 
design 
Influence of sequence 
on hydrogen bond 
alignment, fibril 
twisting and gel 
stiffness 
45 
GWVAVKIEG3A4-OC16 
VAVKIEG3A4W-OC16 
VAVKIEG3A4-COC3H6-Pyrene 
G(K-COCH2Pyrene)EVAVKIEG3A4-OC16 
VAVKIEG3A4(K-COCH2Pyrene)-OC16 
VAVKIEG3A4-OC16 
 
de novo 
design 
Tryptophan and pyrene 
fluorescence of 
solvation of PA fibrils 
46 
C16ONH-A4G3EIKVAV-COOH 
C16ONH-A4G3KYIGSR-CONH2 
C16ONH-C4G3S(Phos)RGDS-COOH 
C16ONH-C4G3KIKVAV-CONH2 
de novo 
design 
Coassembly of PAs with 
oppositely charged 
peptide sequences 
47 
C16ONH-V3A3K3-COOH, C16ONH-V3A3E3-
COOH, 
C12ONHCO-CH2CH(CCONH2)V6K3-NH2, 
C12ONHCO-CH2CH(CCONH2)V3A3E3-NH2, 
de novo 
design 
Mixing of PAs with free 
C- and N- termini 
48 
COOH-GE3L3-COC5H10-(urea oligomer) 
COOH-GE3L3-COC5H10-(urea oligomer) 
COOH-E3L3-COC5H10-(urea oligomer) 
de novo 
design 
Nanofibril formation by 
asymmetric peptide 
bolaamphiphiles 
49 
C16-V3A3K3 de novo 
design 
Formation of 
macroscopic gels and 
membranes at the 
interface of PA and 
hyaluronic acid 
solutions 
50 
 38
C16O-VEVE and C16O-VEVEGRGD de novo 
design 
Nanobelt formation 52 
C16-F3E3, C16-A3E3 de novo 
design 
Twisted ribbon to 
helical ribbon transition 
53 
WRGDSG3A3(K)-C16O 
K(WRGDS-K)KX3A3(K)-C16O; X = G or VCH3 
K(RGDSW-K)KX3A3(K)-C16O; X = G or VCH3 
RGDSG3A3(K)-C16O 
K(RGDS-K)KL3A3(K)-C16O 
(RGDS-K)K(K-RGDS)L3A3(K)-C16O 
DD(RGDS-D)KL3A3(K)-C16O 
K(GRSDSD-K)KL3A3(K)-C16O RGDSD denotes 
cyclic peptide 
de novo 
designs 
incorporating 
RGDS cell 
adhesion 
motif 
Influence of branching 
on PA self-assembly 
54 
C12COOH(CH2)2 D(C12)A2-C10N(CH3)3+ Br- 
Thy-C12COOH(CH2)2 D(C12)F2-C10N(CH3)3+ Br- 
 
Thy denotes thymine 
de novo 
designs 
Use of PA nanofibrils to 
attach gold 
nanoparticles via 
complementary 
interactions 
55 
C16-A6E3, C16-V2A2E2G2REDKETV, C16-
V2A2E2G2TKRE2VD, C16-A2E2G2REDKETV 
de novo 
design 
X-ray induced ordering 56 
C16-V3A3E3 and others de novo 
design 
Formation of aligned 
monodomain strings 
57 
Cn-KTVIIE-NH2; n = 6,8,10,12,14,16 de novo 
design 
Thermal stability as a 
function of alkyl chain 
length 
59 
CnO-KTVIIE-NH(CH2)2-(EO)68-OH; n=6, 8, 10, 
12, 14 
C18ONHCO(nitrobenz)-KTVIIE-NH(CH2)2-
(EO)68-OH  
 
EO denote ethylene oxide 
Nitrobenz denotes a nitrobenzyl unit with linker 
de novo 
design 
Balance between 
hydrophobic/hydrophilic 
self-assembly by 
attachement of PEG. 
UV-induced 
disassembly 
60 
Cn-GANPNAAG; n = 6,8,10,12,14,16 Derived from 
protein of the 
malaria 
parasite P. 
falciparum 
Formation of β-sheet 
structure for sufficiently 
long alkyl chain, and 
thermal stabilization of 
β-sheet 
61 
Influence of cross-
linking polymerization 
of hydrophobic chains 
on chromatic properties 
62 C24CO-GANPNAAG  
C24 chain contains diacetylene at 4,6- 10,12- or 
16,18- positions 
(10,12- derivative) 
Derived from 
protein of the 
malaria 
parasite P. 
falciparum Patterning using 
polarization holography 
63 
C16-G7 with NMeG substitution in 0-6 positions, 
C16-(G6A)ERGDS with A position varied 
de novo  
design 
Fibril secondary 
structure and β-sheet 
packing motif 
65 
C16O-A4K4, C16O-A4H4, C16O-A4E4, C16O-A8K4, 
C16O-A12K4 
de novo 
design 
Templating of silica 
nanotubes by PA 
nanofibrils 
66 
 39
C8-KLVFFAE Amyloid β 
peptide 
sequence 
Aβ(16-22). 
Influence of lipidation 
on β-sheet structure 
67 
(C16)2-E-C2-X; X = G, A, V, K, COOH, AOEt, 
AOBz, IV-H1, IV-H1-GPDPGPDPGPGPDP 
 
[IV-H1] = GNKGNPGWPGAP is a type IV 
collagen sequence 
de novo 
designs and 
modified type 
IV collagen 
sequence 
Formation of 
monolayers at the 
air/water interface, and 
packing within the 
monolayer 
68 
DOPE-(LG)2, DOPE-(LG)3, DOPE-(LG)4 
DOPE = dioleoylphosphatidyl ethanolamine 
de novo 
design 
Ordering of β-sheets in 
monolayers at the 
air/water interface 
69 
C12-EVHHQKL Amyloid β 
peptide 
sequence 
Aβ(11-17). 
 
Amyloid fibrillisation 70 
NH2-SDDFGAIV-SO2-
N(Cn)(CHCH2OH)SCONH2 n = 12, 15, 16, 18  
Modified 
amylin (20-
29) peptide 
Fibrillisation 71 
(C16)2-GC2G, (C16)2-GC2-[IV-H1]-Y 
(C16)2-GC2-(GPHyp)4-[IV-H1], (C14)2-GC2-[IV-
H1]-(GPHyp)4 
Modified 
type IV 
collagen 
sequence and 
control 
Formation of triple-
helical structure and 
enhanced thermal 
stability compared to 
unlipidated peptides  
72 
C6- C8-, C10-, C12- C14- & C16- & (C12)2- 
(GPHyp)4-[IV-H1]-(GPHyp)4 
 
Modified 
type IV 
collagen 
sequence 
Stabilization of polypro 
II triple helical 
structures 
73 
C6- & C16- & (C12)2-G-C2-KA[GIGALKA]2 
KA[GIGALKA]2 
 
 
C6-, C8-, C10-, C12- C14- & C16- & (C12)2-G-C2- 
[GPG]4(GVKGNKGNPGWPGAP)[GPG]4 
de novo 16-
residue coiled 
coil peptide 
 
Collagen-
derived 
Influence of alkyl chain 
on helical secondary 
structure formation, and 
thermal stability 
74 
C16-WAAAAKAAAAKAAAAKA de novo 
design 
Transformation from 
spherical to wormlike 
micelles with 
development of β-sheet 
structure 
75 
C11ONH-VRGDV, C12ONH-VRGDV, C12ONH-
ERGDE, Fmoc-VRGDV 
RGD cell 
adhesion 
motif 
pH effect on self-
assembly 
76 
NH2(CH2)4CHNH2CO-
GPAALKRARNYEAARRSRARKLQRMKQLE-
(EIEALKA)-Kε-C12-MMA 
 
MMA denotes methylmethacrylate 
DNA binding 
sequence and 
coiled-coil 
septet 
Self-assembly 77 
(C18)OCO(CH2)2CH(COOC18)(βA)RGD-COOH RGD cell Cell spreading 78 
 40
(C18)OCO(CH2)2CH(COOC18)(βA)DGR-NH2 
(C18)OCO(CH2)2CH(COOC18)(βA)DGR(βA) 
CH(COOC18)(CH2)2(COOC18) 
 
 
adhesion 
motif 
C16O-RGDS-OC16 
C15O-RGDS 
GRGDS-OCO-C15 
HOCOCH2CH2CO-RGDS-
OCH2CH(OC14)(CH2OC14) 
 
And analogues with substituted alkyl chains 
RGD cell 
adhesion 
motif 
Inhibition of metastasis 79 
Cn-16r-Y-SPARC119-122; n = 6, 10, 14, 16, 18, 
18:1 and 18:1-OH 
 
16r denotes KAEIEALKAEIEALKA 
SPARC119-122 denotes KHGK-NH2 
SPARC 119-
122 sequence 
and 16-
residue coiled 
coil sequence 
Cell adhesion and self-
assembly 
82 
C16O-NH-GTAGLIGQES-COOH 
C16O-NH-GTAGLIGQERGDS-COOH 
C16O-NH-GTALIGQERRDGS 
RGDS cell 
adhesion 
motif (or 
scrambled 
control) and 
MMP 
degradable 
sequence 
Neural cell growth. 
Biodegradability of PA 
network, mechanical 
properties of hydrogels 
83 
Selective differentiation 
of neural progenitor 
cells 
84 C16-A4G3EIKVAV IKVAV cell 
adhesion 
motif 
Treatment of spinal cord 
injury 
85 
C16-V3A3K3RGDS, C16-V3A3K3DGSR and 
C16-V3A3K3, C16-V3A3R3, C16-V3A3E3 (diluents) 
RGDS cell 
adhesion 
motif, 
scrambled 
control and 
diluent PAs 
Growth of bone marrow 
stem and progenitor 
cells 
86 
HSNGLPLG3E3A3V3(K)-COC11H23,  
C16O-V3A3E3 
HSNGLPL 
TGF-β1 
domain 
Cartilage regeneration 87 
C16O-LRKKLGKA Heparin-
binding 
sequence 
Angiogenesis 88 
RGDSKKLLA(K)-C9O-diacetylene-C12 
with KKLLA(K)-C9O-diacetylene-C12 as diluent 
RGDS cell 
adhesion 
motif 
Alignment of stem cells 
using soft lithographic 
photopatterning 
methods 
89 
C16O- A4G3S(Phos)RGD, 
C16O-A4G3EIKVAV 
RGD/IKVAV 
cell adhesion 
motifs 
Alignment of fibrils by 
soft lithography 
90 
 41
RGD-functionalized 
vesicles – adhesion to 
endothelial cells 
81 (C16)2NCICH(EO)4RGDF(K) 
(C16)2N-chalcone-(EO)3RGDF(K) 
 
EO indicates ethylene oxide, chalcone is a 
chromophore unit employed in ref80 
RGD cell 
adhesion 
motif 
RGD-functionalized 
vesicles – adhesion to 
integrins 
80 
Collagen production, 
application in skincare 
products 
91, 92, 95 C16-KTTKS Matrikine 
from 
propeptide 
α1(I) 
collagen212-216
Self-assembly 96 
C16-KTTKS, C16-GHK, C16-GQPR Collagen-
stimulating 
peptides 
LC mass spec to 
monitor PA content in 
anti-wrinkle cosmetics 
93 
(C16)2-GC2-KAbuGRGDSPAbuK, 
(C16)2-GC2- KAbuGRGDSPAbuK-C2-G-(C16)2 
(C16)2-GC2- KAbuGRGESPAbuK-C2-G-(C16)2 
(C16)2-GC2-PHSRN, 
(C16)2-GC2-PHSRN(SG)3-SGRGDSP, 
(C16)2-GC2-GRGESP 
Contain 
synergy 
domain 
PHSRN 
and/or RGDS 
cell adhesion 
motif 
Interaction between PAs 
and α5β1 integrin 
probed by AFM 
97, 98 
(C16)2-GC2-GRGDSP 
(C16)2-GC2-GRGESP 
(C16)2-GC2-PHSRN 
(C16)2-GC2-PHSRN(SG)4RGDSP 
(C16)2-GC2-KSSPHSRN(SG)5RGDSP 
 
Contain 
synergy 
domain 
PHSRN 
and/or 
RGD(E)S 
cell adhesion 
motif  
Influence of motif and 
linker on adhesion and 
proliferation of HUVEC 
cells and fibronectin 
production 
99 
(C16)2-GC2-PHSRN(SG)4RGDSP 
(C16)2-GC2-K(S)2PHSRN(SG)5RGDSP 
(C16)2-GC2-K(S)2PHSRN(G)10RGDSP 
(C16)2-GC2-K(S)2PHSRN(S)10RGDSP 
(C16)2-GC2-PHSRN(SG)5RGDSP 
(C16)2-GC2-K(S)5PHSRN(SG)5RGDSP 
 
Contain 
synergy 
domain 
PHSRN and 
RGDS cell 
adhesion 
motif 
Influence of linker on 
adhesion between PAs 
and α5β1 integrin 
probed by AFM 
100 
C16-(G)3(S)2PHSRN(SG)5RGDSP Contains 
synergy 
domain 
PHSRN and 
RGDS cell 
adhesion 
motif 
Nanofibril formation, 
hydrogelation and 
growth/proliferation of 
HUVEC cells 
101 
C16OWG[(CH2)4NHCOC15]G(LRKLRKRLLR)2-
NH2 
Binding sites 
for LDL 
receptor and 
proteoglycans
Internalization within 
cells 
102 
C16-LSQETFSDLWKLLPEN 
and 
C16-K(rho)LSQETFSDLWKLLPEN 
P53 tumor 
suppressor 
protein 
Mechanism of 
internalization in cells 
103 
 42
rho denotes a rhodamine derivative 
 
sequence 
p5314-29 
C16ONH-GTAGLIGQRGDS-COOH Contains 
MMP-2 
sensitive (and 
RGDS-
containing) 
sequence 
Enzymatic release of 
cisplatin from hydrogel 
108 
DOPE-PEG12-G(EIAALEK)3-NH2, 
DOPE-PEG12-G(KIAALEK)3GW-NH2 
 
SNARE 
protein 
mimics 
Membrane fusion 
induced by 
complementary coiled 
coil peptides 
109 
C12O-YGAAKKAAKAAKKAAKAA 
C12O-YGAKAKAAKAAKAKAAKA 
C12O-KLFKRHLKWKII 
Cationic 
peptides – 
two designed 
and one 
biomimetic 
Antimicrobial activity 
and eukaryotic cell 
toxicity 
110 
C16-KAK, C16-KGK, C16-KKK, G16-K(DK)K, C16-
KLK, C16-K(DK), C16-K 
de novo 
design 
Antimicrobial properties 111 
CnO-GCKPTFRRLKWKTKCG-NH2  
C16O-IKISGKWKAQKRFLKM  
C16O-QALNYEIRGYVIIKP  
 
Underline denotes a cylic peptide (linked through 
cysteine S-S) 
LPS-binding 
peptides 
LPS-neutralizing 
activity and self-
assembly 
114 
C16-C4G3S(Phos)RGD 
 
 
RGD cell 
adhesion 
motif 
Nanofibril formation 
and templating of 
artificial bone 
mineralization 
115 
C16-(SV)2G3S(Phos)RGD 
S(Phos) denotes phosphorylated serine 
RGD cell 
adhesion 
motif 
Templating of artificial 
bone mineralization 
116 
DOPE-(LG)4 
 
de novo 
design 
Biomimetic 
mineralization of CaCO3
117 
[C15COO(CH2)]2CHPO4--
(CH2)2NHCO(CH2)2CO-[HR1(A153 –Q202] 
 
The peptide contains a sequence from heptad 
repeat region 1 (HR1) from the F1 glycoprotein of 
respiratory syncytial virus 
HR1 
sequence 
Synthetic virus-like 
particle stimulating 
antibody production 
122 
Ac-
A(Ox)AEAAEKAAKYAAEAAEKAAKA(Ox)A-
NH2 
Ox denotes ornithine or ornithine-Cn, n=12, 14, 
16, 18, 20 
de novo 
design 
Denaturing agents 123 
(C18)2AhOH-Lys(DTPAGlu)-(AhOH)2-octreotide 
(C18)2AhOH-Lys(DOTA)-(AhOH)2-octreotide 
 
AhOH = 4,7,10,13,16,-19-hexaoxaheneicosanoic 
acid 
Octreotide 
peptide 
MRI contrast agents for 
cancer detection 
124 
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DOTA and DTPAGlu denote chelating agents 
Octreotide = DFCFDWKTCT(ol) underline 
denotes cyclic peptide 
 
 
DβA(K-βADCOOH)L2C4(K)OC16, 
K(K-KNH2)L2C4(K)OC16, 
DβA(K-DSDGR)L3A3(K)OC16, 
 
βA denotes β-alanine 
de novo 
branched 
designs, and 
incorporation 
of RGD cell 
adhesion 
motif 
Encapsulation of carbon 
nanotubes 
125 
Biotin-RGDSKG3A3(K)OC16 
K(K-Biotin-RGDS)X3A3(K)OC16 
(K-Biotin-RGDS)(K-Biotin-RGDS)X3A3(K)OC16 
X = G or VCH3 
de novo 
branched 
designs 
incorporating 
RGDS and 
biotin 
Presentation of biotin on 
PA nanofibrils 
126 
Cn-KTVIIE; n = 6, 8, 10, 12, 14, 16 Model 
amyloid 
forming 
peptide 
Stabilization of β-sheet 
structure 
129 
 
* The difference between Cn labelling of alkyl chain and C denoting cysteine within a 
peptide sequence should be evident from the structure 
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Figures 
 
 
 
 
 
 
Fig.1. Proposed mechanism for nanotube formation by V6D, via the formation of 
peptide bilayers.15 Peptides may form a closed ring based on a bilayer structure. The 
closed rings may stack to form a nanotube. Nanotubes were observed to be connected 
via a three-way junction, a model for which is shown. 
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(a)     (b) 
 
 
 
Fig.2. A6K nanotubes. (a) cryo-TEM image28 and (b) model for nanotube structure. 29 
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Fig.3. (a) Molecular structure of a typical PA studied by the Stupp group, 
incorporating motifs as indicated (the bioactive epitope in this case is the laminin 
IKVAV sequence), (b) Diagram of nanofibril structure, (c) SEM image of nanofibril 
network in DMEM cell medium (d) TEM image.5 
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Fig.4. Schematic showing reversible pH-induced self-assembly and covalent capture 
of PAs containing C4 domains.43 Molecules self-assemble upon acidification and 
disassemble at neutral and basic pH when fully reduced. Oxidized molecules will not 
self-assemble at acidic pH, an observation ascribed to the distorted conformation 
required by intramolecular disulfide bonds. Oxidised fibrils lose their pH sensitivity 
and therefore exhibit enhanced stability.
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Fig.5. (a) TEM image of nanobelts formed by C16O-VEVE, (b) Grooved nanobelts 
form upon increasing pH, (c) Higher magnification image of grooved nanobelts, (d) 
Schematic of morphology transition (e) Formation of twisted nanoribbons at the end 
of a nanobelt, (f) Proposed mechanism of unravelling of tapes on dilution.52 
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Fig.6. Exposure to synchrotron X-rays induces a transition from isotropic- hexagonal 
order for an 0.5 wt% solution of PA C16-A6E3.56 (a) SAXS data, (b) Schematic of 
ordering of PA fibril bundles.
)
)(b
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f
d
Fig.7. (a,b) Noodle-like strings of PA solution (stained with trypan blue) injected into 
phosphate-buffered saline, (c) The same solution dragged through a thin film of 
aqueous CaCl2, (d) Birefringent texture of a gel, (e) Model for plaque, rupturing into a 
bundle of fibrils, (f) Side view of model of break-up of lamellar plaque into fibrillar 
bundles upon cooling.57
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 (a)
(b)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.8. (a) Diacetylene-containing PAs studied by van den Heuvel et al.62, (b) Spatially 
selective polymerization, depending on polarization direction of UV (shown).63 
Darker lines indicate more strongly polymerized fibrils.
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Fig.9. Model of PA fibril structure showing a lipid core, b β-sheet region stabilized 
by H-bonding between four residues, c Peripheral peptide region.65 
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Fig.10. Nanostructure of Matrixyl.130 (a) Confocal microscopy image showing 
fibrillar superstructure extending to near macroscopic scale, (b) Negative stain TEM 
image showing detail of tape-like structure of fibrils at the nanoscale, (c) Model for 
ordering of PA layers perpendicular to tape surface, deduced from SAXS data. 
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Fig.11. Fluorescence microscopy images of live SJSA-1 cells showing (a) 
internalization of PA via rhodamine fluorescence (red), (b) non-PA peptide control 
showing absence of internalization. Nuclei are stained by Hoechst 33342 (blue).103
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Fig.12. Concept of PA-based hydrogel for the bioresponsive release of cisplatin.108 (a) 
Scheme of nanofibrillar network structure within hydrogel, (b) Mechanism of cross-
linking of c-c-e aspartic acid residues or d-f carboxyl termini. 
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The self-assembly of amphiphilic peptides and peptide amphiphiles is reviewed. 
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